Zobrazeno 1 - 10
of 270
pro vyhledávání: '"N. E. Kushlinskii"'
Autor:
N. E. Kushlinskii, O. V. Kovaleva, Yu. B. Kuzmin, E. V. Samoilova, P. L. Prishchep, E. S. Gershtein, S. R. Varfolomeeva, D. V. Rogozhin, N. Yu. Sokolov, K. A. Borzov, E. A. Sushentsov, A. K. Valiev, I. S. Stilidy
Publikováno v:
Успехи молекулярной онкологии, Vol 10, Iss 2, Pp 100-107 (2023)
Introduction. Enzyme-linked immunosorbent assay of biochemical markers is one of the most important methods for diagnosing tumors. One of these markers is an inducer of expression of matrix metalloproteases EMMPRIN/CD147. Changes in its expression ar
Externí odkaz:
https://doaj.org/article/e5a5401085ba4e098a71e484a7840114
Autor:
I. S. Stilidi, O. V. Kovaleva, A. N. Gratchev, E. M. Tchevkina, P. A. Podlesnaya, P. V. Tsarapaev, E. A. Suleymanov, N. E. Kushlinskii
Publikováno v:
Бюллетень сибирской медицины, Vol 21, Iss 3, Pp 96-104 (2022)
Background. Implementation of immunotherapy in clinical oncological practice has significantly improved the results of cancer treatment. It resulted in the need for seeking new markers to assess the effectiveness of therapy and the disease prognosis.
Externí odkaz:
https://doaj.org/article/0eebef41557c48d7b1cd4982a01e79c9
Publikováno v:
Успехи молекулярной онкологии, Vol 8, Iss 3, Pp 8-13 (2021)
Introduction. Immunoenzyme assay of biochemical markers is one of the most important methods for examination of pa- tients with neuroendocrine tumors (NETs). Along with the generally accepted NET marker chromogranin A (CgA), another member of the gra
Externí odkaz:
https://doaj.org/article/abd9af006e9742398414eb8858acfb66
Autor:
N. V. Lyubimova, Yu. S. Timofeev, A. V. Lebedeva, A. V. Artamonova, I. S. Stilidi, N. E. Kushlinskii
Publikováno v:
Успехи молекулярной онкологии, Vol 9, Iss 4 (2022)
Introduction. Carcinoid syndrome is the most common functional syndrome in patients with neuroendocrine tumors. More than 40 biochemical factors are responsible for the manifestation of carcinoid syndrome, among which serotonin is the most important.
Externí odkaz:
https://doaj.org/article/2a33f594a7594d72a7334795ad42bd17
Autor:
N. E. Kushlinskii, O. V. Kovaleva, A. A. Alferov, Yu. B. Kuzmin, E. A. Sushentsov, I. S. Stilidi
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 49, Iss 3, Pp 179-190 (2021)
B7-H3, also called CD276, is a type I transmembrane glycoprotein that is encoded on human chromosome 15. It was discovered back in 2001. The original study described it as a positive co-stimulant, as it can stimulate T-cell response and IFN-y product
Externí odkaz:
https://doaj.org/article/a03455a0f2514df49fd079028033cf3a
Autor:
N. E. Kushlinskii, E. S. Gershtein, A. V. Kolpakov, S. D. Bezhanova, V. V. Mushtenko, E. A. Korotkova, D. Yu. Pushkar, V. V. Bazaev
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 2, Pp 78-83 (2020)
Background: Evaluation and search for new molecular markers of renal cell cancer, first of all, associated with angiogenic and invasive activity, continue to be highly relevant. In our previous publications, we have assessed the potential diagnostic
Externí odkaz:
https://doaj.org/article/6883655858c94f419fd49649dcb38a4b
Publikováno v:
Успехи молекулярной онкологии, Vol 7, Iss 1, Pp 32-37 (2020)
Background. Tumors of stroma of the sex cord include a family of tumors that are diverse in structure and biological characteristics, including hormone-active ovarian tumors, such as granulosa cell tumor (GCT) of the ovary and a tumor from Sertoli–
Externí odkaz:
https://doaj.org/article/9ce6270412e74e63b20340d198bf5a40
Autor:
N. V. Lyubimova, Yu. S. Timofeev, T. K. Churikova, A. A. Markovich, G. S. Emelianova, I. S. Stilidi, N. E. Kushlinskii
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 8, Pp 685-690 (2020)
Background: The utility of biochemical markers in the monitoring of treatment efficacy in patients with neuroendocrine tumors (NETs) goes beyond any doubt. However, there are still no clear criteria for the assessment of clinically significant abnorm
Externí odkaz:
https://doaj.org/article/97c8e18912514a1484b43ce46583cc2c
Autor:
E. A. Braga, I. V. Pronina, D. O. Utkin, E. A. Filippova, A. M. Burdennyy, V. I. Loginov, M. V. Fridman, T. P. Kazubskaya, N. E. Kushlinskii
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 1, Pp 47-53 (2019)
Rationale: We have previously identified a group of microRNA genes (MIR-107, MIR-1258, MIR-130b, MIR-34b/c, MIR-9-1, MIR-9-3 et al.), whose methylation was involved into the development and progression of ovarian cancer. Aim: To expand the range of m
Externí odkaz:
https://doaj.org/article/6ce479813f9143cda6f6345b6464a0ec
Autor:
E. S. Gershtein, D. O. Utkin, I. O. Goryacheva, M. M. Khulamkhanova, N. A. Petrikova, I. I. Vinogradov, A. A. Alferov, I. S. Stilidi, N. E. Kushlinskii
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 46, Iss 7, Pp 690-698 (2018)
Background: Ovarian cancer is one of the most common oncologic diseases holding the frst place in mortality related to neoplasms of female genitalia. Along with active surgical intervention, contemporary ovarian cancer treatment includes various chem
Externí odkaz:
https://doaj.org/article/552b92e7c23f4e73bf1127f6cca06928